Kohlberg Kravis Roberts & Co. L.P.
Position in CHRS — Coherus Oncology, Inc.
CIK 1399770
NEW YORK, NY
Position in CHRS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,250,506
-$880,462 QoQ
Shares Held
3,036,076
0.0% QoQ
Ownership
1.97%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#6
of 145 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CHRS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Kohlberg Kravis Roberts & Co. L.P. holds $991,927,626 across 2 Biotechnology names. CHRS ranks #2 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BBIO |
BridgeBio Pharma, Inc.
|
13,260,971 | $987,677,120 | |
| 2 | CHRS |
Coherus Oncology, Inc.
This page
|
3,036,076 | $4,250,506 |
All Filings in CHRS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,250,506 | 3,036,076 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $5,130,968 | 3,036,076 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,311,227 | 3,036,076 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $4,979,164 | 3,036,076 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,219,371 | 3,036,076 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $2,450,113 | 3,036,076 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $4,189,784 | 3,036,076 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $3,157,519 | 3,036,076 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $5,252,411 | 3,036,076 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $7,256,221 | 3,036,076 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $10,110,133 | 3,036,076 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $12,964,044 | 3,036,076 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $20,766,759 | 3,036,076 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $24,045,721 | 3,036,076 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $29,176,690 | 3,036,076 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $21,981,190 | 3,036,076 | Shares | Other | 2022-08-12 | |
| 2022-03-31 | $39,195,741 | 3,036,076 | Shares | Other | 2022-05-16 | |
| 2021-12-31 | $48,455,772 | 3,036,076 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $48,789,741 | 3,036,076 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $41,988,931 | 3,036,076 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $44,357,070 | 3,036,076 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $52,767,000 | 3,036,076 | Shares | Other | 2021-02-16 | |
| 2020-09-30 | $55,681,633 | 3,036,076 | Shares | Other | 2020-11-16 | |
| 2020-06-30 | $54,224,317 | 3,036,076 | Shares | Other | 2020-08-14 | |
| 2020-03-31 | $49,245,152 | 3,036,076 | Shares | Other | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||